Tag: Bayer

Bayer's stock finds itself trapped between opposing forces, unable to achieve any meaningful momentum. While the company's core operations continue ...

A recent assessment from Fitch Ratings has presented Bayer investors with a complex picture. The agency's decision to affirm the ...

Bayer's latest quarterly results have left investors divided, as a surprise €2.1 billion adjusted operating profit—boosted by a €150 million ...

The pharmaceutical and agrochemical giant has intensified its restructuring, slashing 12,000 full-time jobs—nearly double the figure announced earlier this year. ...